Alibaba Health Information Technology Limited (ALBHF)
| Market Cap | 9.24B |
| Revenue (ttm) | 4.22B |
| Net Income (ttm) | 197.40M |
| Shares Out | n/a |
| EPS (ttm) | 0.01 |
| PE Ratio | 46.81 |
| Forward PE | 29.87 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,800 |
| Average Volume | 91 |
| Open | 0.6000 |
| Previous Close | 0.6660 |
| Day's Range | 0.6000 - 0.6660 |
| 52-Week Range | 0.3200 - 0.8000 |
| Beta | 1.43 |
| RSI | 65.75 |
| Earnings Date | May 23, 2025 |
About ALBHF
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, includi... [Read more]
Financial Performance
In 2024, ALBHF's revenue was 30.60 billion, an increase of 13.22% compared to the previous year's 27.03 billion. Earnings were 1.43 billion, an increase of 62.14%.
Financial numbers in CNY Financial StatementsNews
Alibaba Health: AI-Driven Growth And Digital Healthcare Leadership
Apps in Beijing's crosshairs as crackdown heats up
U.S.-traded shares of several China-based tech-related firms, including Alibaba Holding, Tencent Music Entertainment Group and iQiyi, slid on Thursday in the wake of Beijing's findings that 43 apps il...
China's digital health care start-ups get a boost from the coronavirus, Beijing and investors
The coronavirus pandemic is proving to be the accelerator that China's health care technology start-ups needed.
Alibaba Health raises $1.3 billion in Hong Kong's biggest secondary share sale in 5 years
Chinese healthcare services firm Alibaba Health Information Technology has raised nearly $1.3 billion in Hong Kong's largest follow-on share sale in five years, according a statement from the company ...